Background: While the utilization of integrated backscatter intravascular ultrasound (IB-IVUS) for the quantitative in vivo assessment of coronary plaque continues to grow, the validity of IB-IVUS images obtained from newly developed and conventional systems remains uncertain.
he technique of integrated backscatter intravascular ultrasound (IB-IVUS) utilizes time-domain information from the spectral analysis of radiofrequency data from ultrasound backscatter to resolve differences in plaque characteristics. [1] [2] [3] [4] [5] [6] This has facilitated the in vivo study of coronary atherosclerosis and plaque constituents. 6- 19 The original catheter technology used, Clearview (Boston Scientific, Natick, MA, USA), has previously been extensively validated. However, this platform is limited by its ability to image only every 0.5 mm rather than continuously and the need to immediately post-process the radiofrequency (RF) signal. The VISIWAVE platform (Terumo, Tokyo, Japan) attempts to overcome these limitations, facilitating both continuous image acquisition and offline RF signal analysis. These advances might represent significant advantages for the VISIWAVE system over the Clearview system. However, ultrasound power and therefore RF signal is critically dependent on the equipment being used and might thereby influence the accuracy of the resultant data. Different catheter technologies cannot be assumed to be equivalent. The VISIWAVE system has not been independently validated against the gold-standard of histology or against the established Clearview system. We therefore sought to assess the agreement between the 2 methods as well as against histology.
Methods

In Vivo Validation
Between July 2010 and February 2011, 32 consecutive patients with stable coronary disease who consented to repeated IVUS examinations prior to undergoing percutaneous coronary intervention (PCI) with single everolimus-eluting stent implantation were prospectively recruited to the study. All patients had
Histological and Clinical Validation of IB-IVUS
IB-IVUS and quantitative coronary angiography performed, which was then used to guide subsequent coronary intervention. 20- 22 Only native coronary artery lesions were included in the study. Patients were excluded if they had lesions located in totally occluded or tortuous vessels due to the difficulty in performing precise intracoronary imaging. Those with ostial or left main stem lesions were also excluded. The study was approved by the local ethics committee of the Fujita Health University and was carried out according to the guidelines of the Declaration of Helsinki. Written informed consent was obtained from all patients.
Image Acquisition
A 6 Fr/7 Fr guiding catheter was introduced through the femoral approach after the administration of intravenous heparin at 100 IU/kg. Selective coronary angiography was performed after the intracoronary injection of nitrates. Following the passage of a 0.014 inch guidewire across the lesion, the 2 mechanical IVUS catheters (Atlantis, 40-MHz, 2.5 Fr, Boston Scientific, Natick, MA, USA; and ViewIT, 40-MHz, 2.5 Fr, Terumo, Tokyo, Japan) were serially introduced over the wire and positioned distal to the lesion. 22- 24 The lesion was then imaged using motorized pullback (0.5 mm/s). The IB-IVUS system (IB-IVUS, YD Co, Ltd, Nara, Japan) was connected to the IVUS imaging systems (VISIWAVE, Terumo, Tokyo, Japan and Clearview, Boston Scientific, MA, USA) with RF, signal trigger and video image outputs to obtain the RF signal during acquisition. Ultrasound backscattered signals were acquired, digitized and subjected to spectral analysis and stored electronically together with IVUS images for offline analysis. All the lesions were then treated with stent implantation using standard techniques at the operator's discretion. IVUS was used to ensure adequate stent expansion and was then repeated to ensure successful stent deployment. [24] [25] [26] Image Analysis Intracoronary image analysis was performed by the consensus of 3 experienced blinded observers (Y.O., M.O., K.H.) with no access to clinical records during assessment. We compared the 2 IB-IVUS systems to each other in vivo using 200 crosssections of clinical plaques from 32 arteries in the 32 patients undergoing coronary intervention. The IVUS-verified crosssectional luminal area was defined as the integrated area central to the intimal leading edge echo. 22-24 The total vessel cross-sectional area was defined as the area inside the interface between the plaque-media complex and the adventitia (area inside the external elastic membrane). Local landmarks such as side-branches and calcium deposits, as well as the topology of the lumen, were used to ensure that comparable frames were assessed for both IB-IVUS systems. 22 The plaque components were automatically determined by spectral analysis of RF data (IB-IVUS, YD Co, Ltd, Nara, Japan) from both IB-IVUS systems for regions-of-interest (ROI) drawn on identical frames from each IB-IVUS system when viewed side-by-side (Figure 1 ).
Ex Vivo Histological Validation
We examined 125 diseased coronary arterial cross-sections of 26 coronary arteries obtained from 11 cadavers. Of these patients, 7 had symptomatic cardiovascular disease (64%). The coronary arteries were dissected within 24 h of death. The harvested coronary arteries were immediately fixed with 10% buffered formalin solution and stored for more than 24 h. After formalin fixation, arterial segments were subjected to IVUS imaging in phosphate-buffered saline at a temperature of 37°C. To clarify the rotational and cross-sectional position of the included segment, multiple surgical needles were carefully inserted into the coronary arteries before IB-IVUS imaging to serve as reference points to compare the IB-IVUS images with histology. This method has been successfully applied in previous studies that compared histology and IVUS images. 12,15,27, 28 After placing the needles, the catheter (Atlantis, Boston Scientific, Natick, MA, USA) was advanced into the coronary arteries and pulled back at 0.5 mm/s by activating an auto-pullback device. The IB-IVUS images were acquired at an interval of 1 image per second during the auto-pullback procedure. The same procedure was then performed using the other catheter (ViewIT, Terumo, Tokyo, Japan). Cross-sectional images from sites containing surgical needles and from sites within 1 mm of the surgical needles were obtained to ensure that IB-IVUS and histology were compared at the same site. After the images were acquired, imaging sites were sutured by stitches that were attached to the surgical needles to serve as a reference point to compare IVUS images with histology. Ring-like sections of arteries obtained at the same level as the imaging study were decalcified for 5 h, embedded with paraffin and cut perpendicular to the longitudinal axis of the artery into 2 µm sections. They were stained with haematoxylin-eosin, elastic van Gieson's and Masson's trichrome stains.
We performed a histological comparison between histological sections, and IB-IVUS images acquired by Clearview and VISIWAVE systems using the same cross-sections (Figure 2A) . 12, 15, 27 In the histological comparison, histology/ IVUS image pairs were classified into 3 categories: calcific, fibrous and lipid-rich according to our previous studies. 12, 27 The inter-observer agreements of IB-IVUS for tissue characterization of plaque type were excellent (Cohen's κ=0.90). 26 In addition, we performed a "direct" comparison by setting small (0.3×0.3 mm) ROI at the same locations within the IVUS images. Histological classification (fibrous, lipid pool and calcification) in the direct comparison was performed as previously reported ( Figure 2B ). 12, 15 When there were more than 2 diagnoses in the ROI, the diagnosis that occupied more than half of the area was used. When there were more than 3 diagnoses in the ROI, the ROI was excluded from the comparison. A total of 115 ROIs were compared.
Statistical Analysis
All continuous values are expressed as mean ± SD for normally distributed variables or as medians and interquartile ranges for non-parametric data. The Kolmogorov-Smirnov test was used to assess the normality of continuous data. In the experimental study, the individual categorical measurements of IB-IVUS parameters derived from the 2 IVUS systems were compared with the histological diagnosis using unweighted Cohen's κ coefficients. 29 Marginal homogeneity was assessed using the Bhapkar and Stuart-Maxwell tests. Continuous in vivo data from the 2 imaging systems were compared using the methods of Bland and Altman as well as by calculating concordance correlation coefficients, assessing both precision (Pearson's ρ) and accuracy (bias correction factor). 30 Passing and Bablok regression analysis was used to assess the equality of measure- 
Results
Baseline clinical and angiographic characteristics at the time of intervention for the in vivo group are summarised in Table 1 .
The group was representative of the spectrum of patients with stable atherosclerotic coronary disease seen in clinical practice.
IB-IVUS Images Compared With Histology
A total of 125 cross-sections were diagnosed as lipid-rich, fibrous and calcific by the IVUS reader who was blinded to the histological diagnoses. In the histological comparison, the overall agreement between the histological and IB-IVUS diagnoses using VISIWAVE (Cohen's κ=0.82, 95% confidence interval (CI): 0.73-0.90) was similar to that using Clearview (Cohen's κ=0.80, 95%CI 0.71-0.89) (Table 2A; Figure 2A ). In the direct in vitro comparison using small (0.3×0.3 mm) ROI at the same sites within the IVUS images, the overall agreement between IB-IVUS diagnoses using VISIWAVE and Clearview was also excellent (Cohen's κ=0.87, 95%CI: 0.78-0.95) ( Figure 2B ; Table 2B ). There were no statistically significant differences between the classification of plaque by histology and either IB-IVUS system, or in the classifications obtained when the 2 systems were compared with each other in vivo as assessed with the Bhapkar or Stuart-Maxwell tests of marginal homogeneity (Tables 2A,B) . The sensitivity and specificity of the 2 techniques relative to the gold standard of histology was also high and very comparable ( Table 2C) .
The precision and accuracy of quantitative measures of plaque characteristics as assessed by the 2 IB-IVUS systems, as well as greyscale IVUS parameters, were assessed using the methods of Bland and Altman as well as by evaluating the concordance between measurements in 200 cross-sections of clinical plaques in the 32 patients (Figure 3 ). There were no statistically significant differences between the continuous measurements of plaque characteristics made with either IB-IVUS system ( Table 3) . Greyscale IVUS parameters were also highly comparable ( Table 3) . There was a similarly strong agreement between the 2 techniques when assessed with the concordance coefficient for all greyscale parameters as well as for the lipid percentage and total fibrous plaque percentage, with values typically exceeding 0.95. There was weaker concordance between the 2 techniques with respect to their assessment of the percentage of plaque deemed calcified with a concordance coefficient of 0.77. When this concordance coefficient was decomposed to its constituents, the bias correction factor -a measure of accuracy -was excellent at 0.98; however, the Pearson coefficient was 0.78 suggesting reduced precision or repeatability for this parameter. Nevertheless, Passing and Bablok regression did not identify any significant deviation from linearity for this or any of the other parameters ( Table 4 ; Figure 4 ). The 95% limits of agreement for calcified plaque percentage were also relatively high at -1.9% and 2.4% and gave mean values of 1.19% and 1.35% with VISIWAVE and Clearview, respectively. There was a trend for increased deviation from linearity for higher calcified plaque percentages but this did not reach statistical significance. Bland and Altman analysis confirmed the absence of any significant systematic bias in the measurements obtained by the 2 techniques and corroborated the assessments made using the concordance coefficient (Figures 3,4) for both IB-IVUS and greyscale IVUS parameters. 
Discussion
Our study demonstrates a close agreement between both the Clearview and VISIWAVE IB-IVUS systems and the gold standard of histology for major plaque constituents. Both systems demonstrated both high sensitivity and specificity in their ability to classify plaque types. We also demonstrated close concordance between the 2 techniques with respect to continuous measures of plaque composition as well as greyscale IVUS vessel dimensions. Importantly, there was no tendency of either technique to systematically under or overestimate any of the measured parameters.
While there was close agreement between the 2 IB-IVUS systems, this was not perfect, and there are a number of sources of potential variation that might explain the variability in results. In addition to random measurement error, our comparison strategy required in vivo imaging with the 2 catheters at precisely the same location. Despite the use of local anatomical landmarks and other precautions to ensure accurate image registration, minor inconsistencies are inevitable. In addition, the guidewire used to deploy the imaging catheters is echo-reflective and renders a small sector of the vessel opaque. Variations in guidewire position between image acquisition runs might therefore have resulted in minor variations in the sectors of the vessel rendered opaque. 31,32 This effect might have been particularly important for small plaque constituents such as plaque calcium and might, in part, explain the reduced precision observed in concordance analysis for this plaque type. Calcium is also a strong reflector of ultrasound and might have rendered underlying plaque constituents opaque by casting an acoustic shadow, contributing to variations between histological and IB-IVUS assessment. 22, 33 Superimposed on all of these effects is the impact of inter-observer variability.
Clinical Implications
In keeping with previous studies, our study demonstrates a close correspondence between IB-IVUS findings and histology. 12,15,27,34 While the Clearview system has been in widespread use, the newer VISIWAVE system has hitherto not been fully validated in common experimental and clinical settings to support its widespread application as an imaging tool for evaluating atherosclerosis. Our work provides the validation data required for its application in vivo. In addition, we have shown it to perform as well as the established IB-IVUS system. Importantly, however, the VISIWAVE system has a number of clear advantages over the Clearview system in that it allows continuous image acquisition rather than every 0.5 mm, as well as the ability to process data offline. The ability to image vessels continuously allows full plaque coverage and is likely to greatly facilitate future serial comparison studies by minimising sampling error and allowing comprehensive plaque assessment. By providing estimates of the variability between the 2 systems, our work also facilitates comparisons between new data acquired with the VISIWAVE platform and historical data as well as the design of future studies.
IB-IVUS technologies, by enabling the in vivo characterisation of plaque constituents, allow the evolution of atherosclerotic plaque over time to be evaluated. As well as facilitating such important natural history studies, IB-IVUS provides the opportunity for assessing the impact of therapeutic interventions on plaque constituents through serial plaque evaluation. The accurate histological and clinical validation of new catheter technologies is of particular importance in this context.
Study Limitations
Our study has a number of limitations. The number of patients investigated is relatively low but reflects the difficulties in obtaining post-mortem specimens and the costs involved in performing intravascular imaging. Nevertheless, we managed to study a representative sample of clinical patients as well as histological specimens that are likely to reflect cases encountered in the typical application of both IB-IVUS systems.
Despite the precautions taken to ensure identical image slices were compared when assessing the 2 systems in vivo and in vitro, it is possible there might have been some discrepancies in slice positioning, particularly for the histological assessment where the process of sectioning the artery segments might have generated artifacts or resulted in mis-registration. However, the high level of agreement between the 2 techniques observed suggests that any such effects are likely to have had a minimal impact.
In addition, it is possible that repeated vessel instrumentation with the imaging catheters might have caused injury to the vessel wall. While this cannot be completely excluded as an explanation of the variation seen between the catheter technologies, the absence of any procedural complications following imaging and the very strong agreement between the 2 techniques imply that the impact if any of iatrogenic vessel injury was minimal.
For the histological assessment, we stained tissue only with haematoxylin-eosin, elastic van Gieson's and Masson's trichrome stains. Other stains focused on lipids such as oil red O or Sudan III stains were not used in the present study. Nevertheless, we believe that the panel of stains chosen will have enabled comprehensive histological plaque characterization.
In the present comparison, IB-IVUS data was obtained from coronary specimens after formalin fixation. It is possible that the fixation process by removing free water might have altered tissue characteristics; however, it has previously been shown that formalin fixation does not significantly affect the quantitative echo characteristics of plaque tissue from human aortic walls. 27,34, 35 Finally, our cohort was comprised of patients with stable atherosclerotic coronary artery disease. Patients with acute coronary syndromes were not studied because of the inability of IB-IVUS to differentiate thrombus at its different stages of evolution from other plaque constituents. 5,10,17 All intravascular imaging was conducted at the same sitting, therefore the evolution of plaque components in the short timescale of the procedure is not likely to have occurred. The inability to accurately delineate thrombus is a limitation of all IVUS technologies. Our histological validation data is therefore only applicable to the stable coronary disease population. Nevertheless, they provide a strong foundation for using this technology together with other invasive and non-invasive imaging modalities to characterise atherosclerotic plaque.
Conclusions
Both systems for IB-IVUS demonstrated close agreement with each other and with the histological assessment of plaque characteristics. They therefore provide a robust means of invasively assessing plaque characteristics in vivo and might provide valuable insights into the pathophysiology of atherosclerosis, as well as a means of assessing the effects of therapeutic interventions. OHOTA M et al.
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